GOLDMAN SACHS GROUP INC

Position in VKTX — Viking Therapeutics, Inc.

CIK 886982 NEW YORK, NY

Back to VKTX Full portfolio

Position in VKTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$36,780,226

+$5,523,279 QoQ

Shares Held

942,841

-1.8% QoQ

Ownership

0.808%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#14

of 435 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Derivatives in VKTX

reported options exposure · as of Dec 31, 2025

CallValue

$5,118,690

CallShares

145,500

PutValue

$897,090

PutShares

25,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. VKTX ranks #86 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,481,761	$1,232,765,138
2	REGN	Regeneron Pharmaceuticals, Inc.	1,163,191	$725,296,113
3	ROIV	Roivant Sciences Ltd.	18,556,458	$656,713,046
4	TECH	BIO-TECHNE Corp	7,343,324	$518,805,838
5	RVMD	Revolution Medicines, Inc.	2,133,101	$399,487,154
6	MRNA	Moderna, Inc.	4,671,950	$327,176,656
7	TNGX	Tango Therapeutics, Inc.	9,980,620	$311,994,180
8	INCY	Incyte Corp	2,305,782	$261,383,446

All Filings in VKTX

Export CSV

36 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$36,780,226	942,841	-1.8%	Shares	Defined	2026-08-14
2026-03-31	$31,256,947	960,570	+15.4%	Shares	Defined	2026-05-15
2025-12-31	$29,292,662	832,651	+211.0%	Shares	Defined	2026-03-25
2025-12-31	$897,090	25,500	-27.1%	Put	Defined	2026-03-25
2025-12-31	$5,118,690	145,500	+142.5%	Call	Defined	2026-03-25
2025-09-30	$7,036,312	267,744	+74.5%	Shares	Defined	2025-11-14
2025-09-30	$1,576,800	60,000	-33.3%	Call	Defined	2025-11-14
2025-06-30	$4,065,576	153,418	+10.1%	Shares	Defined	2025-08-14
2025-06-30	$2,385,000	90,000	+100.0%	Call	Defined	2025-08-14
2025-03-31	$1,086,750	45,000	+350.0%	Call	Defined	2025-06-27
2025-03-31	$3,365,423	139,355	+37.0%	Shares	Defined	2025-06-27
2024-12-31	$4,092,487	101,702	-35.1%	Shares	Defined	2025-02-11
2024-12-31	$402,400	10,000	-92.2%	Call	Defined	2025-02-11
2024-12-31	$1,408,400	35,000	+75.0%	Put	Defined	2025-02-11
2024-09-30	$9,921,879	156,719	-85.4%	Shares	Defined	2024-11-14
2024-06-30	$6,801,183	128,300	-34.6%	Call	Defined	2024-08-13
2024-06-30	$56,943,340	1,074,200	+67.3%	Shares	Defined	2024-08-13
2024-06-30	$1,060,200	20,000	—	Put	Defined	2024-08-13
2024-03-31	$52,660,072	642,196	-42.7%	Shares	Defined	2024-05-15
2023-12-31	$20,841,059	1,119,885	+88.3%	Shares	Defined	2024-05-14
2023-09-30	$6,582,099	594,589	-14.2%	Shares	Defined	2024-05-15
2023-06-30	$11,231,291	692,862	+2.8%	Shares	Defined	2024-05-14
2023-03-31	$11,218,536	673,786	+745.2%	Shares	Defined	2024-05-14
2023-03-31	$3,266,730	196,200	—	Call	Defined	2024-05-14
2022-12-31	$749,367	79,720	+115.3%	Shares	Defined	2024-05-14
2022-09-30	$100,734	37,035	-35.4%	Shares	Defined	2024-05-14
2022-06-30	$165,761	57,357	-78.0%	Shares	Defined	2024-05-14
2022-03-31	$781,047	260,349	+199.3%	Shares	Defined	2022-05-16
2021-12-31	$400,186	86,997	-38.1%	Shares	Defined	2022-02-17
2021-09-30	$883,036	140,611	-51.8%	Shares	Defined	2022-01-20
2021-06-30	$1,748,966	291,981	+495.4%	Shares	Defined	2021-08-13
2021-03-31	$310,196	49,043	-36.9%	Shares	Defined	2021-05-17
2020-12-31	$437,844	77,770	-87.6%	Shares	Defined	2021-02-12
2020-09-30	$3,637,639	625,024	+8.5%	Shares	Defined	2020-11-13
2020-06-30	$4,154,069	576,154	+592.6%	Shares	Defined	2020-08-12
2020-03-31	$389,323	83,189	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.